Nanobubbles containing PD-L1 Ab and miR-424 mediated PD-L1 blockade, and its expression inhibition to enable and potentiate hepatocellular carcinoma immunotherapy in mice-Reference-Cited by-同舟云学术

Nanobubbles containing PD-L1 Ab and miR-424 mediated PD-L1 blockade, and its expression inhibition to enable and potentiate hepatocellular carcinoma immunotherapy in mice

Published:2022-12 Issue: Volume:629 Page:122352
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Liu Yun,Xie Qian,Ma Yao,Lin Chen,Li Jinlin,Hu Bing,Liu Chaoqi,Zhao Yun

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference37 articles.

1. Roles of PD-1/PD-L1 pathway: signaling, cancer, and beyond;Ai;Adv Exp Med Biol.,2020

2. Modulating microRNAs in cancer: Next-generation therapies.;Arghiani;Cancer Biol Med.,2021

3. Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance;Bagchi;Annu Rev Pathol.,2021

4. Trends in the development of miRNA bioinformatics tools;Chen;Brief Bioinform.,2019

5. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response;Chen;Nature.,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomal miRNA-146a and miRNA-424 as possible predictors of immune checkpoint inhibitors therapy response in clear cell renal cell carcinoma;Генетика;2024-08-26

2. miR-200a-3p promotes the malignancy of endometrial carcinoma through negative regulation of epithelial-mesenchymal transition;Discover Oncology;2024-06-25

3. MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways;Cancer Cell International;2024-03-10

4. Exosomal miRNA-146a and miRNA-424 as Possible Predictors of Immune Checkpoint Inhibitors Therapy Response in Clear Cell Renal Cell Carcinoma;Russian Journal of Genetics;2024-03

5. Efficient ultrasound-mediated drug delivery to orthotopic liver tumors – Direct comparison of doxorubicin-loaded nanobubbles and microbubbles;Journal of Controlled Release;2024-03